Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

Jun 08 • 04:00PM ET

7.71

+0.24 3.21 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN INCY RYTM KYMR NUVL VKTX AXSM NBIX

| Held by: VTI VXF IBB SURI SCHA DWAS IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.28	Insider Own	38.20%	Shs Outstand	60.53M	Perf Week	-6.20%
Market Cap	468.73M	Forward P/E	-	EPS next Y	-2.94	Insider Trans	1.06%	Shs Float	37.57M	Perf Month	-17.10%
Enterprise Value	266.04M	PEG	-	EPS next Q	-0.68	Inst Own	42.34%	Short Float	14.06%	Perf Quarter	-8.21%
Income	-156.40M	P/S	-	EPS this Y	21.28%	Inst Trans	0.85%	Short Ratio	5.63	Perf Half Y	-1.66%
Sales	0.00M	P/B	2.39	EPS next Y	-2.66%	ROA	-60.42%	Short Interest	5.28M	Perf YTD	-17.98%
Book/sh	3.23	P/C	1.98	EPS next 5Y	13.10%	ROE	-74.55%	52W High	13.67 -43.60%	Perf Year	127.43%
Cash/sh	3.89	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-68.79%	52W Low	2.52 205.95%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.72% 7.20%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	2.58%	Oper. Margin	-	ATR (14)	0.59	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.15	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.96	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.15	EPS Q/Q	36.35%	SMA20	-12.59%	Beta	1.99	Target Price	30.40
Payout	-	Debt/Eq	0.17	Sales Q/Q	-	SMA50	-14.54%	Rel Volume	0.69	Prev Close	7.47
Employees	130	LT Debt/Eq	0.16	Earnings	May 12 AMC	SMA200	0.25%	Avg Volume	938.24K	Price	7.71
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.20% -	Trades		Volume	651,590	Change	3.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)